Showing results (2131-2140 of 8,157) with videos related to

Sort By:
Pageof 816
Haematologica|June 2, 2016
Severe Ankyrin-R deficiency results in impaired surface retention and lysosomal degradation of RhAG in human erythroblastsTimothy J Satchwell, Amanda J Bell, Bethan R Hawley, et al.
Haematologica|June 2, 2016
Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trialHaifa Kathrin Al-Ali, Martin Griesshammer, Philipp le Coutre, et al.
Haematologica|May 14, 2016
Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter surveyZyrafete Kuçi, Halvard Bönig, Hermann Kreyenberg, et al.
Haematologica|July 22, 2017
Notch2 blockade enhances hematopoietic stem cell mobilization and homingWeihuan Wang, Shuiliang Yu, Jay Myers, et al.
Haematologica|August 12, 2017
Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasmLaure Philippe, Adam Ceroi, Elodie Bôle-Richard, et al.
Haematologica|August 5, 2017
Endotoxemia shifts neutrophils with TIMP-free gelatinase B/MMP-9 from bone marrow to the periphery and induces systematic upregulation of TIMP-1Jennifer Vandooren, Wannes Swinnen, Estefania Ugarte-Berzal, et al.
Haematologica|August 5, 2017
Chronic lymphocytic leukemia cells are active participants in microenvironmental cross-talkMartijn Ha van Attekum, Eric Eldering, Arnon P Kater
Haematologica|August 5, 2017
Incidence and management of toxicity associated with ibrutinib and idelalisib: a practical approachIris de Weerdt, Suzanne M Koopmans, Arnon P Kater, et al.
Haematologica|August 5, 2017
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphomaAlessandro Broccoli, Cinzia Pellegrini, Alice Di Rocco, et al.
Haematologica|September 2, 2017
HIF1A is a critical downstream mediator for hemophagocytic lymphohistiocytosisRui Huang, Yoshihiro Hayashi, Xiaomei Yan, et al.
Pageof 816